Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais G R, Lupien P J, Després J P
Lipid Research Center, CHUL Research Center, Ste-Foy, Québec, Canada.
Circulation. 1997 Jan 7;95(1):69-75. doi: 10.1161/01.cir.95.1.69.
Case-control studies have reported that patients with ischemic heart disease (IHD) have a higher proportion of small, dense LDL particles than do healthy control subjects. The extent to which the risk attributed to small LDL particles may be independent of concomitant variations in plasma lipoprotein-lipid concentrations remains to be clearly determined, however, particularly through prospective studies.
Baseline characteristics were obtained in 2103 men initially free of IHD, among whom 114 developed IHD during a 5-year follow-up period. These 114 case patients were matched with healthy control subjects for age, body mass index, smoking habits, and alcohol intake. LDL peak particle diameter (PPD) was measured a posteriori in 103 case-control pairs by nondenaturing gradient gel electrophoresis of whole plasma. Conditional logistic regression analysis of the case-control status revealed that men in the first tertile of the control LDL-PPD distribution (LDL-PPD < or = 25.64 nm) had a 3.6-fold increase in the risk of IHD (95% CI, 1.5 to 8.8) compared with those in the third tertile (LDL-PPD > 26.05 nm). Statistical adjustment for concomitant variations in LDL cholesterol, triglycerides, HDL cholesterol, and apolipoprotein B concentrations had virtually no impact on the relationship between small LDL particles and the risk of IHD.
These results represent the first prospective evidence suggesting that the presence of small, dense LDL particles may be associated with an increased risk of subsequently developing IHD in men. Results also suggest that the risk attributed to small LDL particles may be partly independent of the concomitant variation in plasma lipoprotein-lipid concentrations.
病例对照研究报告称,缺血性心脏病(IHD)患者中,小而密低密度脂蛋白颗粒的比例高于健康对照者。然而,尤其是通过前瞻性研究,小低密度脂蛋白颗粒所致风险在多大程度上可能独立于血浆脂蛋白-脂质浓度的伴随变化,仍有待明确确定。
对2103名最初无IHD的男性进行了基线特征评估,其中114人在5年随访期内发生了IHD。这114例病例患者在年龄、体重指数、吸烟习惯和酒精摄入量方面与健康对照者进行了匹配。通过对全血浆进行非变性梯度凝胶电泳,对103对病例对照者事后测量了低密度脂蛋白峰值颗粒直径(PPD)。对病例对照状态进行条件逻辑回归分析显示,处于对照低密度脂蛋白-PPD分布第一三分位数(低密度脂蛋白-PPD≤25.64 nm)的男性发生IHD的风险比处于第三三分位数(低密度脂蛋白-PPD>26.05 nm)的男性高3.6倍(95%CI,1.5至8.8)。对低密度脂蛋白胆固醇、甘油三酯、高密度脂蛋白胆固醇和载脂蛋白B浓度的伴随变化进行统计调整,对小低密度脂蛋白颗粒与IHD风险之间的关系几乎没有影响。
这些结果代表了首个前瞻性证据,表明小而密低密度脂蛋白颗粒的存在可能与男性随后发生IHD的风险增加有关。结果还表明,小低密度脂蛋白颗粒所致风险可能部分独立于血浆脂蛋白-脂质浓度的伴随变化。